Investor Type | Firm |
Type of Fund | VC |
Industries | Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • AgroTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • Sales (& Marketing) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Analytics • Food & Beverage • Human Resources • Impact • Material Science • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Oncology • Consumer • Pharmaceutical (& Medicine) |
Stages | Early Stage, Expansion, Later Stage, MBO/LBO, Turnaround, Recapitalization, Consolidation, Special Situations, Series A, Seed, Series B |
Investing | United States • United Kingdom • Switzerland • Israel • Europe |
Investment Range | $500,000 - $15,000,000 |
Investment Sweet Spot | $7,000,000 |
Assets Under Management | $100,000,000 |
Flagship Pioneering is a venture capital firm that specializes in fostering innovation across a wide range of industries including Software, IT, BioTech, AgroTech, Business Solutions, FinTech, Hardware, Energy, Retail, Sales, CleanTech, A.I., HealthTech, Food & Beverage, Human Resources, Impact, Material Science, Medical Devices, Healthcare, Oncology, Consumer, and Pharmaceutical sectors. With headquarters in Cambridge, Massachusetts, the firm was founded in 2000 and holds expertise in equity investments, with an emphasis on early-stage, expansion, later-stage, MBO/LBO, turnaround, recapitalization, consolidation, special situations, Series A, Seed, Series B financing rounds. Flagship Pioneering operates with a minimum investment threshold of $500,000 and a maximum of $15,000,000, aiming for an investment sweet spot of $7,000,000. They manage assets totaling $100,000,000. The firm is renowned for developing platforms and building companies that significantly influence and potentially change the world. On their website, they highlight initiatives and programs such as Pioneering Medicines, Pioneering Intelligence, Preemptive Health & Medicine, Flagship Global Engagement, and their Flagship Fellowship. They have established numerous partnerships with major industry players to spur innovation in medicine and beyond and take pride in their portfolio companies like Moderna, Tessera Therapeutics, Generate:Biomedicines, and Inari Agriculture. They are particularly notable for their focus on regenerative medicine and for their active role in shaping the direction of biotechnological research and deployment.